The COVID-19 pandemic has changed patient care in countless ways, but percutaneous coronary intervention (PCI) remains the recommended standard of care for ST-segment elevation myocardial infarction (STEMI) patients.

CMS has announced that healthcare providers in communities experiencing low numbers of confirmed COVID-19 cases may be able to once again provide more in-person care unrelated to the virus.

Newer-generation drug-eluting stents (n-DES) are a more effective option for the percutaneous treatment of small-vessel coronary disease (SVCD) than drug-coated balloons (DCBs), according to new findings published in JACC: Cardiovascular Interventions.

One side effect of this unprecedented time is that many fourth-year medical students are being asked to join the pandemic’s front lines before they have even graduated.

Substituting butter, margarine, mayonnaise or dairy fat with olive oil can lower a person’s risk of coronary heart disease (CHD) and total cardiovascular disease (CVD), according to new research published in the Journal of the American College of Cardiology.

“If the devices haven’t been properly validated for accuracy, treatment decisions could be based on incorrect information.”

Forward-looking providers are converting reams of data from myriad sources into innovative new ways to deliver healthcare and improve efficiencies.

If three or more significant and similar occurrences signify a trend, the U.S. hospitals that have closed in the heat of the COVID-19 crisis—mostly rural institutions—may be harbingers of things to come.